KRAS and neoplasm: Another recent study using a mouse AT2 cell‐based 3D organoid model demonstrated that the Kras G12D mutation can induce a ‘damage/plasticity’ intermediate state before tumour formation, maintaining cells in a state between AT2 and AT1 differentiation.187